3h
Hosted on MSNFDA removes clinical hold on Entrada’s Duchenne therapyEntrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...
1d
GlobalData on MSNFDA approves Mirum’s Ctexli for cerebrotendinous xanthomatosisMirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with ...
A study reveals safety differences in generic drugs based on where they're made, urging stronger regulatory oversight.
"Under the updated 'healthy' claim, nutrient-dense foods that are encouraged by the Dietary Guidelines — vegetables, fruits, ...
The U.S. Food and Drug Administration has named seafood exporters with unsafe levels of PFAS, also known as "forever ...
The FDA announced that a food distributor is recalling all ReadyCare and Sysco Imperial Frozen Supplemental shakes, typically ...
The NGO Doctors for America argued that HHS, CDC and FDA violated federal law in removing medical information from ...
The National Association of Attorneys General has submitted a letter to the U.S. Food and Drug Administration, signed by a ...
As almost 75% of US adults are overweight or obese, the US Food and Drug Administration has announced a simple, mandatory ...
FDA feedback confirms Adial's proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results